Details for New Drug Application (NDA): 074962
✉ Email this page to a colleague
NDA 074962 describes PENTOXIL, which is a drug marketed by Upsher Smith Labs and is included in one NDA. Additional details are available on the PENTOXIL profile page.
The generic ingredient in PENTOXIL is pentoxifylline. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
The generic ingredient in PENTOXIL is pentoxifylline. There are fourteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
Summary for 074962
| Tradename: | PENTOXIL |
| Applicant: | Upsher Smith Labs |
| Ingredient: | pentoxifylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 074962
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 400MG | ||||
| Approval Date: | Mar 31, 1999 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
